Session 1: Dr. Andrew Hruszkewycz Memorial Session on Measuring and Targeting Lineage Plasticity to Prevent Lethal Prostate Cancer
Thursday, October 28, 2021 | 7:04 AM – 8:30 AM PST
Moderator:
Andrew Armstrong, MD, ScM, Duke University
A Tale of Two Evasions: Lineage Plasticity and Tumor Heterogeneity
Ping Mu, PhD, UT Southwestern Medical Center at Dallas
Measuring CRPC Cellular Heterogeneity at the Single Cell Level to Inform Treatment Strategies
Eliezer Van Allen, MD, PhD, Harvard: Dana-Farber Cancer Institute
Measuring Lineage Plasticity and Heterogeneity in mCRPC with Liquid Biopsies to Inform Treatment
Andrew Armstrong, MD, ScM, Duke University
Targeting Transformed Neuroendocrine Cells to Overcome Treatment Resistance
Amina Zoubeidi, PhD, Vancouver Prostate Centre, Canada